Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
08/2011
08/30/2011US8008513 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
08/30/2011US8008510 Metalloprotein inhibitors
08/30/2011US8008499 Anabaseine derivatives, pharmaceutical compositions and methods of use thereof
08/30/2011US8008315 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
08/30/2011US8008305 TAAR1 ligands
08/30/2011US8008302 ((2S,3S) N,2-dihydroxy-5-methyl-3-{[4-(2-pyridinyl)-1-piperazinyl]carbonyl}hexanamide; for treatment and/or prevention of disorders related to autoimmune disorders and/or inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, stroke, cancer, pre-term labor, endometriosis
08/30/2011CA2672373C Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
08/30/2011CA2672256C Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2h)-yl)-n,4-dimethylbenzamide
08/30/2011CA2531165C A method for the preparation of enantiomerically pure mirtazapine
08/30/2011CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
08/25/2011WO2011103536A1 Multifunctional radical quenchers and their use
08/25/2011WO2011103196A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
08/25/2011WO2011102348A1 Hydrazide chelate complex compound and optical recording medium using same
08/25/2011WO2011100829A1 Bifunctional chelating agents
08/25/2011US20110207935 Fused-ring derivative and medical application of same
08/25/2011US20110207783 Renin inhibitors
08/25/2011US20110207747 2,5-Disubstituted Phenyl Carboxamide Orexin Receptor Antagonists
08/25/2011US20110207739 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof
08/25/2011US20110207036 Electrophoretic Particle Salt For Electrophoretic Display And Method Of Making
08/25/2011US20110204354 Indenopyrene compound and organic light-emitting device using the compound
08/25/2011CA2789711A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
08/24/2011EP2360136A1 Production of alkenones
08/24/2011EP2358679A2 Process for making (r) - 3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido [2,3-d] pyrimidine-4,7 (3h,8h)-dione and intermediates thereof
08/24/2011EP2358678A1 Process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides
08/24/2011EP2358677A1 Naphthylacetic acids used as crth2 antagonists or partial agonists
08/24/2011EP1485353B1 New inhibitors of histone deacetylase
08/24/2011CN1984889B Organometallic complex, luminous solid, organic EL element and organic EL display
08/24/2011CN102164920A Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof as FAAH enzyme inhibitor
08/24/2011CN102164898A Process for the synthesis of halogenated cyclic compounds
08/24/2011CN102164896A Phenethylamide derivatives and their heterocyclic analogues
08/24/2011CN102164895A Method for the preparation of 3-methylpyridine
08/24/2011CN102164894A Heteroaryl antagonists of prostaglandin D2 receptors
08/24/2011CN102161641A Pyridone complex
08/24/2011CN102161640A 3,5-diaminopyridine and preparation method of 3,5-dimethoxycarboxylaminopyridine
08/24/2011CN102161639A Method for synthesizing pyridinium hydroxy propyl sulfobetaine
08/24/2011CN102161607A Method for preparing fluorine-containing aromatic compound
08/24/2011CN101506166B Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds
08/24/2011CN101096592B Organometallic compounds and emission-shifting organic electrophosphorescence
08/23/2011US8003799 Picolinic acid derivatives and their use as fungicides
08/23/2011US8003797 Pyridine carboxamide orexin receptor antagonists
08/23/2011US8003791 Boronic ester and acid compounds, synthesis and uses
08/18/2011WO2011098417A1 Substituted cyanobutyrates having herbicidal action
08/18/2011WO2011098380A1 Bipyridyl-substituted anthracene derivatives and use thereof in organic electroluminescent arrangements
08/18/2011WO2011077043A3 Phenol derivatives and pharmaceutical or cosmetic use thereof
08/18/2011WO2011046991A3 Certain substituted ureas as modulators of kinase activity
08/18/2011WO2011041737A3 Gain-of-function bcl-2 inhibitors
08/18/2011WO2010074751A8 Stable sulfoximine-insecticide compositions
08/18/2011US20110201820 Method for producing alcohol compound
08/18/2011US20110201819 Method for producing alcohol compound
08/18/2011US20110201817 Levodopa prodrugs, and compositions and uses thereof
08/18/2011US20110201816 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites
08/18/2011US20110201811 Dihydropyridine calcium antagonist compounds, preparation methods, and medical uses thereof
08/18/2011US20110201635 Substituted spiroindolinones
08/18/2011US20110201616 Sulfonamide compounds or salts thereof
08/18/2011US20110201610 Aryl sulfonamides
08/18/2011US20110201609 Proteasome inhibitors for selectively inducing apoptosis in cancer cells
08/18/2011US20110201603 Novel Acylaminobenzamide Derivatives
08/18/2011US20110201602 Protein kinase modulators and method of use
08/18/2011US20110201591 Isonicotinamide orexin receptor antagonists
08/18/2011US20110200549 Organic Compounds Suitable For Modulating Fragrance Compositions
08/18/2011US20110200535 Daa-pyridine as peripheral benzodiazepine receptor ligand for diagnostic imaging and pharmaceutical treatment
08/18/2011DE102010054866A1 Composition, useful e.g. for bleaching and/or dyeing hair and as oxidative cleaning formulation, comprises substance comprising hydrogen peroxide and hydrogen peroxide releasing substances, water and substances comprising hydroxypyridones
08/18/2011DE102010054865A1 Use of a substance including hydroxypyridone and its salt for stabilizing a substance including hydrogen peroxide and hydrogen peroxide releasing substance
08/17/2011EP2357174A1 Salt forms of (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-penten-2-amine
08/17/2011EP2357173A1 New alkyne compounds with MCH-antagonistic activity and medicaments containing them
08/17/2011EP2356094A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
08/17/2011EP1966129B1 Carbonates of fenicol antibiotics
08/17/2011EP1773775B1 Six-membered heterocycles useful as serine protease inhibitors
08/17/2011EP1670772B1 Derivatives of 1,3-diones having a herbicidal activity
08/17/2011EP1644330B1 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids
08/17/2011EP1511713B1 Compounds that abrogate dna-damage-induced cell cycle g2 checkpoint and/or augment the anti-cancer activity of dna-damaging treatments
08/17/2011EP1379507B1 HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS
08/17/2011CN1894236B Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
08/17/2011CN102160233A Dye-sensitized photovoltaic device
08/17/2011CN102159547A Heterocyclic carboxamide compounds
08/17/2011CN102159546A Aminopyridine kinase inhibitors
08/17/2011CN102159545A Small molecule leptin receptor modulators
08/17/2011CN102159544A Pyridyl modulators of gamma-secretase
08/17/2011CN102159543A Novel triazolo(4,3-a)pyridine derivatives, process for preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
08/17/2011CN102159537A Organic compounds for applications in bacterial infections treatment
08/17/2011CN102159535A Potassium ion channel modulators & uses thereof
08/17/2011CN102159208A 6-1h-imidazo-quinazoline and quinolines derivatives, new mao inhibitors and imidazoline receptor ligands
08/17/2011CN102153592A Suzuki-Miyaura coupling reaction of catalyzing aryl chloride by N-heterocyclic carbine-palladium-imidazole complex at room temperature under condition of water phase
08/17/2011CN102153588A Adefovir pharmaceutical co-crystal and preparation method thereof
08/17/2011CN102153551A Indazole/azaindazole-based diarylcarbamide/thiocarbamide-structure antineoplastic drug
08/17/2011CN102153510A 1,3,5,7-tetra(4-pyridylformyloxy)adamantane compound and synthesis
08/17/2011CN102153509A Preparation method of 2-chloro-3-aminopyridine
08/17/2011CN102153508A 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone and application of the 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone in preparing antitumour drugs
08/17/2011CN102153507A Preparation method of 2,3-dichloropyridine
08/17/2011CN102153506A Insecticidal n-substituted (6-haloalkylpyridin-3-yl)alkyl sulfoximines
08/17/2011CN102153433A N-monosubstituted-alpha-carbonylamide compound and preparation method thereof
08/17/2011CN102151262A Compounds for the treatment of metabolic disorders
08/17/2011CN101531630B Asymmetric chiral double-Schiff base simple synthesizing method
08/17/2011CN101445481B Forcipate thioacid amide ligand, complex compound and application of sulfo-2, 6-pyridine diformamide framework
08/17/2011CN101304972B Process for the preparation of pyridylcarboxylic amides and esters
08/16/2011US7999109 CCR9 inhibitors and methods of use thereof
08/16/2011US7999090 Fungal cell wall synthesis gene
08/16/2011US7999010 Indene derivatives as pharmaceutical agents
08/16/2011US7998986 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors
08/16/2011US7998982 Amide derivatives as TRPV1 antagonists
1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 633